The inhibition of MS by curcumin is mainly by the regulation of inflammatory cytokines such as IL-1β, IL-6, IL-12, TNF-α, IFN-γ and associated JAK-STAT, AP-1, and NF-kappaB signaling pathways [407]. This evidence concerns the gene IFNG and myeloid sarcoma.